| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
149 Leu)]
Divisions of Endocrinology (T.T.N., T.O., I.D.H.), Molecular Genetics (K.E.K., J.F.O.), Medical Genetics (P.S.K.), and Laboratory Medicine and Pathology (T.B.C.), Mayo Clinic and Foundation, Rochester, Minnesota 55905; and Gladstone Institute of Cardiovascular Disease (Z.-S.J., R.W.M.), Cardiovascular Research Institute, and Departments of Pathology and Medicine (R.W.M.), University of California, San Francisco, California 94141
Address all correspondence and requests for reprints to: Tu T. Nguyen, M.D., Division of Endocrinology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905. E-mail: nguyen.tu{at}mayo.edu
Splenomegaly with sea-blue histiocytes is not associated with
dyslipidemia, except in severe cases of hypertriglyceridemia, Tangier
disease, or lecithin cholesterol acyltransferase deficiency. We
describe two kindreds in which the sea-blue histiocyte syndrome was
associated with an apoE variant in the absence of severe dyslipidemia.
Both patients presented with mild hypertriglyceridemia and
splenomegaly. After splenectomy both patients developed severe
hypertriglyceridemia. Pathological evaluation of the spleen revealed
the presence of sea-blue histiocytes. A mutation of apoE was
demonstrated, with a 3-bp deletion resulting in the loss of a leucine
at position 149 in the receptor-binding region of the apoE molecule
[apoE (
149 Leu)]. Although both probands were unrelated, they were
of French Canadian ancestry, suggesting the possibility of a founder
effect. In summary, we describe two unrelated probands with primary
sea-blue histiocytosis who had normal or mildly elevated serum
triglyceride concentrations that markedly increased after splenectomy.
In addition, we provide evidence linking the syndrome to an inherited
dominant mutation in the apoE gene, a 3-bp deletion on the background
of an apoE 3 allele that causes a derangement in lipid metabolism and
leads to splenomegaly in the absence of severe hypertriglyceridemia.
This article has been cited by other articles:
![]() |
A. R. Rahalkar, J. Wang, S. Sirrs, J. Dimmick, D. Holmes, N. Urquhart, R. A. Hegele, and A. Mattman An Unusual Case of Severe Hypertriglyceridemia and Splenomegaly Clin. Chem., March 1, 2008; 54(3): 606 - 610. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |